Sentry Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,156
Closed -$396K 533
2021
Q2
$396K Hold
2,156
0.1% 207
2021
Q1
$330K Sell
2,156
-10,296
-83% -$1.59M 0.09% 230
2020
Q4
$1.95M Hold
12,452
0.1% 206
2020
Q3
$1.43M Hold
12,452
0.08% 233
2020
Q2
$1.4M Sell
12,452
-1,337
-10% -$142K 0.09% 238
2020
Q1
$1.24M Buy
13,789
+10,740
+352% +$1.05M 0.09% 198
2019
Q4
$330K Buy
+3,049
New +$326K 0.02% 419
2019
Q3
Sell
-4,934
Closed -$646K 486
2019
Q2
$646K Sell
4,934
-8,169
-62% -$1.05M 0.04% 367
2019
Q1
$1.77M Sell
13,103
-1,163
-8% -$145K 0.12% 187
2018
Q4
$1.39M Sell
14,266
-374
-3% -$44.2K 0.1% 216
2018
Q3
$2.04M Hold
14,640
0.12% 191
2018
Q2
$1.82M Sell
14,640
-887
-6% -$104K 0.12% 198
2018
Q1
$1.73M Sell
15,527
-1,493
-9% -$178K 0.11% 219
2017
Q4
$2.04M Hold
17,020
0.11% 211
2017
Q3
$2.39M Hold
17,020
0.09% 191
2017
Q2
$2.07M Hold
17,020
0.08% 201
2017
Q1
$2.06M Sell
17,020
-783
-4% -$101K 0.08% 196
2016
Q4
$2.18M Hold
17,803
0.09% 192
2016
Q3
$2.18M Buy
17,803
+591
+3% +$76.1K 0.1% 183
2016
Q2
$2.01M Hold
17,212
0.09% 184
2016
Q1
$2.4M Hold
17,212
0.11% 153
2015
Q4
$3.28M Buy
17,212
+1,876
+12% +$328K 0.15% 113
2015
Q3
$2.4M Buy
15,336
+959
+7% +$175K 0.12% 143
2015
Q2
$2.6M Buy
14,377
+545
+4% +$94.1K 0.12% 146
2015
Q1
$2.4M Buy
13,832
+1,959
+16% +$355K 0.11% 147
2014
Q4
$2.2M Hold
11,873
0.11% 153
2014
Q3
$1.97M Sell
11,873
-1,155
-9% -$190K 0.1% 157
2014
Q2
$2.04M Buy
13,028
+2,928
+29% +$462K 0.11% 164
2014
Q1
$1.54M Hold
10,100
0.08% 188
2013
Q4
$1.34M Buy
10,100
+4,000
+66% +$480K 0.07% 197
2013
Q3
$709K Buy
6,100
+1,200
+24% +$132K 0.04% 309
2013
Q2
$452K Buy
+4,900
New +$472K 0.03% 334

Other funds holding ALXN